Publications
5532 Results
- Journal / Conference
- ASCO 11:261(#856)
- Year
- 1992
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8600
A randomized investigation of high-dose (HDAC) versus standard dose (SDAC) cytosine arabinoside with daunorubicin (DNR) in patients with acute myelogenous leukemia.
- Journal / Conference
- ASCO 11:262(#857)
- Year
- 1992
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8600
Biologic parameters that predict treatment response in de novo acute myeloid leukemia (AML): CD34, but not multidrug resistance (MDR) gene expression, is associated with a decreased complete remission (CR) rate and CD34+ patients more frequently achieve CR with high dose cytosine arabinoside.
- Journal / Conference
- ASCO 11:264(#866)
- Year
- 1992
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8600
Biochemical modulation of anthracycline resistance (MDR) in acute leukemia with cyclosporin-A (CSA).
- Journal / Conference
- AACR 33:467(#2792)
- Year
- 1992
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8624
Quantitative PCR analysis of MDR1 mRNA in patients with multiple myeloma.
- Journal / Conference
- ASCO 11:316(#1069)
- Year
- 1992
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8624
Impact of glucocorticoids (GC) and interferon (IFN) on outcome in multiple myeloma.
- Journal / Conference
- ASCO 11:264(#868)
- Year
- 1992
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8691 (INT-0073)
A randomized comparison of deoxycofomycin (DCF) versus alpha-2a interferon (IFN) in previously untreated patients with hairy cell leukemia (HCL): An NCI-sponsored intergroup study. (SWOG, ECOG, CALGB, NCIC-CTG).
- Journal / Conference
- ASCO 11:166(#479)
- Year
- 1992
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8721
A phase II trial of trimetrexate in the treatment of esophageal cancer: A Southwest Oncology Group trial.
- Journal / Conference
- ASCO 11:212(#663)
- Year
- 1992
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8794
Adjuvant radiotherapy following radical prostatectomy for pathologic stage C adenocarcinoma of the prostate: Initial evaluation of toxicity.
- Journal / Conference
- ASCO 11:206(#637)
- Year
- 1992
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8802
Phase II trial of echinomycin in advanced renal cell carcinoma: A Southwest Oncology Group study.
- Journal / Conference
- ASCO 11:292(#974)
- Year
- 1992
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8812